What is the appropriate treatment for erysipelas?

Treatment of Erysipelas

For typical erysipelas, treat with penicillin (500 mg four times daily) or amoxicillin (500 mg three times daily) for 7-10 days, as streptococci cause the vast majority of cases and penicillin remains the therapeutic reference. 1, 2

First-Line Antibiotic Selection

The IDSA guidelines clearly establish that therapy for erysipelas should include an antibiotic active against streptococci, as these organisms are responsible for the vast majority of cases 1. The evidence strongly supports:

• Penicillin or amoxicillin as first-line agents for uncomplicated erysipelas 1, 2
• Oral therapy is appropriate for most patients from the start 1
• Alternative oral options include: cephalexin, dicloxacillin, or clindamycin 1
• For severe cases requiring IV therapy: penicillin G remains the therapeutic reference 2, 3

The Staphylococcus aureus Coverage Controversy

You do NOT need to routinely cover Staphylococcus aureus in typical erysipelas. This is a critical clinical distinction:

• Combined microbiological and serological data demonstrate streptococci cause the vast majority of erysipelas cases 4
• Cure rates with penicillin monotherapy (to which most MSSA are resistant) are comparable to broader-spectrum antibiotics 4
• A 2019 systematic review found no evidence that antibiotics with MRSA activity added any advantage 5
• The recommendation to empirically cover MSSA is weak and based on low-quality evidence 4

Route of Administration

Oral antibiotics are as effective as IV antibiotics for uncomplicated erysipelas:

• The 2019 Cochrane systematic review found no evidence supporting IV antibiotics over oral antibiotics 5
• Most patients can receive oral medications from the start 1
• IV therapy should be reserved for patients with severe systemic features (high fever, hypotension), inability to take oral medications, or severe immunodeficiency 1
• If IV therapy is needed, continuous infusion pumps for benzyl penicillin are safe, effective, and increase penicillin use substantially (73% higher probability of penicillin treatment) 6

Treatment Duration

7-10 days is the recommended duration 1:

• The IDSA guidelines recommend 7-10 days for uncomplicated cases 1
• The 2019 systematic review found no evidence supporting treatment duration longer than 5 days, though this reflects lack of quality data rather than definitive evidence for shorter courses 5
• German and Austrian practice surveys show median treatment duration of 10 days 3

When to Obtain Cultures

Skip cultures for typical erysipelas:

• Blood cultures and tissue samples are unnecessary for typical cases 1
• Obtain blood cultures only if the patient has: malignancy, severe systemic features (high fever, hypotension), neutropenia, severe immunodeficiency, or unusual exposures (immersion injury, animal bites) 1

Adjunctive Measures

Consider these supportive interventions 3:

• Anticoagulation prophylaxis based on individual thrombosis risk factors 2
• Treatment of predisposing local factors (especially interdigital tinea pedis) 3
• Limb immobilization and elevation 3
• NSAIDs for symptom relief, though evidence for routine co-prescription with antibiotics is limited 2

Prevention of Recurrence

For patients with recurrent erysipelas 2:

• Benzathine penicillin injection every 2-4 weeks is the best prophylactic strategy 2
• Address underlying predisposing factors (lymphedema, tinea pedis, venous insufficiency) 3

Common Pitfalls to Avoid

• Don't reflexively use broad-spectrum antibiotics covering MSSA/MRSA for typical erysipelas—this drives resistance without improving outcomes 5, 4
• Don't automatically hospitalize for IV therapy—oral antibiotics work equally well for uncomplicated cases 5
• Don't confuse erysipelas with purulent collections (abscesses, furuncles)—the latter require drainage as primary treatment, not just antibiotics 1
• Don't ignore the face—facial erysipelas is still erysipelas and responds to the same streptococcal-targeted therapy 1